SOLIFENACIN/TAMSULOSIN TEVA 6MG/0,4 MG TBL MRL 100
Rychlý přehled
| Dosage form | Tablets with controlled release |
|---|---|
| Výdej | Ne, lék nelze získat bez receptu. |
| Úhrada / doplatek / cena | Ano, podmínky úhrady (vykazovací limit) ale nebyl stanoven. Maximální doplatek: 957,40 Kč. Maximální cena: 2 103,73 Kč. |
| Kdo může předepsat | Prescription is not conditional on a medical specialization. |
| Složení | Solifenacin-sukcinát (6 mg), solifenacin (4,5 mg), tamsulosin-hydrochlorid (0,4 mg), tamsulosin (0,37 mg), makrogol 7000000, mikrokrystalická celulosa 200 xlm, koloidní bezvodý oxid křemičitý, magnesium-stearát, hydroge… |
| Dostupnost / výpadek | Výpadek The latest report from the manufacturer is from 10. 7. 2026. Výroba byla přerušena od 10. 7. 2026. The stated reason was: Výrobní důvody. Resumption of supply is expected 31. 7. 2026Výrobce jako potenciální náhradu uvádí léky s kó… |
| Kód SÚKL | 0263556 |
What is the maximum co-payment for SOLIFENACIN/TAMSULOSIN TEVA?
If the insurance company contributes, the maximum co-payment is 957,40 Kč. The maximum pharmacy price is 2 103,73 Kč. A pharmacy may provide the medicine for a lower price, but not for a higher price.
Does the medicine have reimbursement from public health insurance?
Yes, but the reimbursement conditions (reporting limit) have not been set.
Does SOLIFENACIN/TAMSULOSIN TEVA have a counted co-payment set?
Yes, the medicine has a counted co-payment of 957,00 Kč. Learn more about the protective limit here.
How much does the insurance company pay for one dispensed reimbursed pack?
1 146,33 Kč.
Does the insurance company pay a higher amount in some cases?
No, the medicine has no increased reimbursement.
Does the medicine have an indication restriction?
Is it available without a medical prescription?
No, the medicine cannot be obtained without a prescription.
Which medical specialist may prescribe SOLIFENACIN/TAMSULOSIN TEVA?
Prescription is not conditional on a medical specialization.
What is the composition of SOLIFENACIN/TAMSULOSIN TEVA?
Solifenacin-sukcinát (6 mg), solifenacin (4,5 mg), tamsulosin-hydrochlorid (0,4 mg), tamsulosin (0,37 mg), makrogol 7000000, mikrokrystalická celulosa 200 xlm, koloidní bezvodý oxid křemičitý, magnesium-stearát, hydrogenfosforečnan vápenatý, silicifikovaná mikrokrystalická celulosa 90, částečně substituovaná hyprolosa, hypromelosa 2910/6, makrogol 8000, červený oxid železitý. More information about the composition can be found in the SPC, section 6.1.
Where can I find information about correct use of the medicine?
Which medicines are similar to SOLIFENACIN/TAMSULOSIN TEVA?
The medicine belongs to ATC group G04CA53 – . Medicines with the same active substance can be found here.
Who manufactures SOLIFENACIN/TAMSULOSIN TEVA?
Informace o výrobci není dostupná.
Is the medicine in shortage?
The latest report from the manufacturer is from 10. 7. 2026. Production was interrupted as of 10. 7. 2026. The stated reason was: Výrobní důvody.
Resumption of supply is expected 31. 7. 2026
The manufacturer lists medicines with the following code as a potential substitute:
What is the unique code for SOLIFENACIN/TAMSULOSIN TEVA?
The medicine has code 0263556. Code details can be found here.
How many packs of SOLIFENACIN/TAMSULOSIN TEVA were previously dispensed on prescriptions in Czechia?
Show prescription medicine consumption
How many packs of SOLIFENACIN/TAMSULOSIN TEVA were previously dispensed on request forms in Czechia?
Show request-form medicine consumption
Z čeho se skládá maximální cena léku?
The page was last updated on 17. 07. 2026